131 related articles for article (PubMed ID: 22035857)
1. ABO blood type is associated with endometrial cancer risk in Chinese women.
Xu WH; Zheng W; Xiang YB; Shu XO
Chin J Cancer; 2011 Nov; 30(11):766-71. PubMed ID: 22035857
[TBL] [Abstract][Full Text] [Related]
2. Association between ABO blood type and type I endometrial cancer: a retrospective study.
Wei S; Yi T; OuYang Z; Wu J
J Obstet Gynaecol; 2023 Dec; 43(1):2153026. PubMed ID: 36606697
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive and IUD use and endometrial cancer: a population-based case-control study in Shanghai, China.
Tao MH; Xu WH; Zheng W; Zhang ZF; Gao YT; Ruan ZX; Cheng JR; Gao J; Xiang YB; Shu XO
Int J Cancer; 2006 Nov; 119(9):2142-7. PubMed ID: 16823853
[TBL] [Abstract][Full Text] [Related]
4. Weight history and risk of endometrial cancer among Chinese women.
Xu WH; Xiang YB; Zheng W; Zhang X; Ruan ZX; Cheng JR; Gao YT; Shu XO
Int J Epidemiol; 2006 Feb; 35(1):159-66. PubMed ID: 16258056
[TBL] [Abstract][Full Text] [Related]
5. ABO and Rh blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of South-East Siberia.
Yuzhalin AE; Kutikhin AG
Asian Pac J Cancer Prev; 2012; 13(10):5091-6. PubMed ID: 23244116
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives and endometrial cancer: do other risk factors modify the association?
Stanford JL; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Hoover RN
Int J Cancer; 1993 May; 54(2):243-8. PubMed ID: 8486426
[TBL] [Abstract][Full Text] [Related]
7. Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany.
Gitas G; Proppe L; Alkatout I; Tsolakidis D; Rody A; Kotanidis C; Baum S
Blood Transfus; 2020 Nov; 18(6):465-470. PubMed ID: 32530401
[TBL] [Abstract][Full Text] [Related]
8. ABO blood group and the risk of pancreatic cancer.
Wolpin BM; Chan AT; Hartge P; Chanock SJ; Kraft P; Hunter DJ; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2009 Mar; 101(6):424-31. PubMed ID: 19276450
[TBL] [Abstract][Full Text] [Related]
9. ABO blood group and breast cancer incidence and survival.
Gates MA; Xu M; Chen WY; Kraft P; Hankinson SE; Wolpin BM
Int J Cancer; 2012 May; 130(9):2129-37. PubMed ID: 21633955
[TBL] [Abstract][Full Text] [Related]
10. Risk factors among young women with endometrial cancer: a Danish case-control study.
Parslov M; Lidegaard O; Klintorp S; Pedersen B; Jønsson L; Eriksen PS; Ottesen B
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):23-9. PubMed ID: 10649152
[TBL] [Abstract][Full Text] [Related]
11. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
Brinton LA; Hoover RN
Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
[TBL] [Abstract][Full Text] [Related]
12. Insulin and endometrial cancer.
Troisi R; Potischman N; Hoover RN; Siiteri P; Brinton LA
Am J Epidemiol; 1997 Sep; 146(6):476-82. PubMed ID: 9290508
[TBL] [Abstract][Full Text] [Related]
13. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies.
Collaborative Group on Epidemiological Studies on Endometrial Cancer
Lancet Oncol; 2015 Sep; 16(9):1061-1070. PubMed ID: 26254030
[TBL] [Abstract][Full Text] [Related]
14. Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies.
Rota M; Rumi F; Bagnardi V; Dal Maso L; Zucchetto A; Levi F; La Vecchia C; Tavani A
BJOG; 2016 Jan; 123(2):285-92. PubMed ID: 26541752
[TBL] [Abstract][Full Text] [Related]
15. Preoperative levels of plasma micronutrients are related to endometrial cancer risk.
Jeong NH; Song ES; Lee JM; Lee KB; Kim MK; Yun YM; Lee JK; Son SK; Lee JP; Kim JH; Hur SY; Kwon YI
Acta Obstet Gynecol Scand; 2009; 88(4):434-9. PubMed ID: 19235557
[TBL] [Abstract][Full Text] [Related]
16. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.
Dossus L; Rinaldi S; Becker S; Lukanova A; Tjonneland A; Olsen A; Stegger J; Overvad K; Chabbert-Buffet N; Jimenez-Corona A; Clavel-Chapelon F; Rohrmann S; Teucher B; Boeing H; Schütze M; Trichopoulou A; Benetou V; Lagiou P; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Redondo ML; Travier N; Sanchez MJ; Altzibar JM; Chirlaque MD; Ardanaz E; Bueno-de-Mesquita HB; van Duijnhoven FJ; Onland-Moret NC; Peeters PH; Hallmans G; Lundin E; Khaw KT; Wareham N; Allen N; Key TJ; Slimani N; Hainaut P; Romaguera D; Norat T; Riboli E; Kaaks R
Endocr Relat Cancer; 2010 Dec; 17(4):1007-19. PubMed ID: 20843938
[TBL] [Abstract][Full Text] [Related]
17. Case-control study of endogenous steroid hormones and endometrial cancer.
Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
[TBL] [Abstract][Full Text] [Related]
18. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
[TBL] [Abstract][Full Text] [Related]
19. Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai.
Xu WH; Xiang YB; Ruan ZX; Zheng W; Cheng JR; Dai Q; Gao YT; Shu XO
Int J Cancer; 2004 Feb; 108(4):613-9. PubMed ID: 14696129
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen therapy for breast cancer and endometrial cancer risk.
Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L
J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
